Japan Drug Delivery Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Japan Drug Delivery Devices Market is segmented By Route of Administration (Injectable, Topical, Ocular and Others), Application and By End User.

Market Snapshot

Market Snapshot1
Study Period: 2018 - 2026
Base Year: 2019
CAGR: 4.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Japan Drug Delivery Devices Market is expected to register a CAGR of nearly 4.5% during the forecast period. The major factors driving the Japan Drug Delivery Devices Market are the rising prevalence of chronic diseases and technological advancements.

Drug delivery devices help in delivering the drugs which are beneficial for the targeted population to recover faster. In addition, a rising number of cancers, respiratory are diabetic patients in Japan will promote the adoption of drug delivery devices and drive the overall market. For instance, according to the estimates of the National Cancer Center - Center for Cancer Control and Information Services, the cancer incidence in 2018 was 1,013,600 in Japan, while the most common types of cancer were colorectum, stomach, lung, breast, and prostate cancer. Thus, owing to the above-mentioned factors is expected to drive market growth over the forecast period.

Scope of the report

As per the scope, drug delivery devices or system are the tools which are used to deliver the drug through the specific route of administration. It enables the introduction of therapeutic substances in the body. The Japan Drug Delivery Devices Market is segmented by route of administration, application and end user.

By Route of Administration
Injectable
Topical
Ocular
Other Route of Administration
By Application
Cancer
Cardiovascular
Diabetes
Infectious diseases
Other Applications
By End User
Hospitals
Ambulatory Surgical Centers
Other End Users

Report scope can be customized per your requirements. Click here.

Key Market Trends

By Application Cancer is Estimated to Witness a Healthy Growth Over The Forecast Period

Over the years, cancer incidence and mortality have increased in Japan. For instance, according to the World Health Organization (WHO), 2018 statistics indicate that the deaths due to cancer increased to nearly 409,400, in Japan. The increasing mortality rate has been a concerning factor for the Japanese government over the years. As a result, the government and other organizations are taking initiatives to spread awareness regarding cancer and its treatments which is expected to boost the market. Thus, the rising prevalence of cancer and the presence of better R&D infrastructure in the country is expected to drive market growth in the near future.

japan key trend 1.png

To understand key trends, Download Sample Report

Competitive Landscape

The Japan Drug Delivery Devices Market is fragmented competitive and consists of several major players. Some of the companies which are currently dominating the market are Mylan N.V., ANTARES PHARMA, INC., Tasei Kako Co. Ltd., GlaxoSmithKline Plc, Novartis AG, Bayer AG, Becton, Dickinson and Company, Johnson & Johnson and 3M Company.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Prevalence of Chronic Diseases

      2. 4.2.2 Technological Advancements

    3. 4.3 Market Restraints

      1. 4.3.1 Risk of Needlestick Injuries

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Route of Administration

      1. 5.1.1 Injectable

      2. 5.1.2 Topical

      3. 5.1.3 Ocular

      4. 5.1.4 Other Route of Administration

    2. 5.2 By Application

      1. 5.2.1 Cancer

      2. 5.2.2 Cardiovascular

      3. 5.2.3 Diabetes

      4. 5.2.4 Infectious diseases

      5. 5.2.5 Other Applications

    3. 5.3 By End User

      1. 5.3.1 Hospitals

      2. 5.3.2 Ambulatory Surgical Centers

      3. 5.3.3 Other End Users

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Mylan N.V.

      2. 6.1.2 Antares Pharma, Inc.

      3. 6.1.3 Tasei Kako Co. Ltd.

      4. 6.1.4 GlaxoSmithKline Plc

      5. 6.1.5 Novartis AG

      6. 6.1.6 Bayer AG

      7. 6.1.7 Becton, Dickinson and Company

      8. 6.1.8 Johnson & Johnson

      9. 6.1.9 3M Company

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Japan Drug Delivery Devices Market market is studied from 2018 - 2026.

The Japan Drug Delivery Devices Market is growing at a CAGR of 4.5% over the next 5 years.

Mylan N.V., ANTARES PHARMA, INC., Tasei Kako Co. Ltd., GlaxoSmithKline Plc, Novartis AG are the major companies operating in Japan Drug Delivery Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!